Scientists have developed an innovative approach to treating Parkinson’s patients—administering a naturally occurring growth factor directly into the brain. The reason? While the research is ongoing, the study’s authors hypothesize that introducing Glial Cell Line-Derived Neurotrophic Factor via robot-assisted, surgically-implanted ports could regenerate dying dopamine neurons. (Journal of Parkinson’s Disease)
